PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Eine durchschnittliche Folge dieses Podcasts dauert 20m.
Bisher sind 622 Folge(n) erschienen.
.
Gesamtlänge aller Episoden: 10 days 18 hours 42 minutes
A Look at Emerging SMA Outcomes: Highlights of EAN 2020
A Look at Emerging SMA Outcomes: Highlights of EAN 2020
Deciphering the Role of MET Alterations in Advanced NSCLC: Unmet Needs
Deciphering the Role of MET Alterations in Advanced NSCLC: Unmet Needs
Are All Biologics the Same? Optimal Treatment Strategies for Patients With Inflammatory Bowel Disease
Visit https://www.peervoice.com/HHQ860 to view the entire programme with slides.
New Targets, New Hope in SMA: A 2020 Congress Coverage
New Targets, New Hope in SMA: A 2020 Congress Coverage
Practice-Changing Perspectives in CMV: Managing the Burden in HSCT and SOT
Practice-Changing Perspectives in CMV: Managing the Burden in HSCT and SOT
Transforming the Treatment of Acute Hepatic Porphyria
Transforming the Treatment of Acute Hepatic Porphyria
Extending Your Interdisciplinary Understanding of IL-6R Inhibitors in Rheumatoid Arthritis
Visit https://www.peervoice.com/DED860 to view the entire programme with slides.
New Targets, New Hope in SMA: A 2020 Congress Coverage
New Targets, New Hope in SMA: A 2020 Congress Coverage